Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders Equity (unaudited)

v3.24.1.1.u2
Consolidated Statements of Stockholders Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Receivable From Shareholder
Preferred Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Jan. 31, 2023   9,923   1,600      
Balance, amount at Jan. 31, 2023 $ 23,550 $ 1 $ (200) $ 0 $ (1,691) $ 85,975 $ (60,535)
Warrant exercise 100 0 100 0 0 0 0
Stock based compensation 641 0 0 0 0 641 0
Net loss (1,819) 0 0 0 0 0 (1,819)
Balance, amount at Apr. 30, 2023 22,472 $ 1 (100) $ 0 (1,691) 86,616 (62,354)
Balance, shares at Apr. 30, 2023   9,923   1,600      
Balance, shares at Jan. 31, 2024   16,903   1,503      
Balance, amount at Jan. 31, 2024 18,606 $ 1 0 $ 0 0 86,991 (68,386)
Stock based compensation 393 0 0 0 0 393 0
Net loss (1,384) $ 0 0 0 0 0 (1,384)
Issuance of common stock, shares   353          
Issuance of common stock, amount 229 $ 1 0 0 0 228 0
Stock issued in exchange for accounts payable, shares   155          
Stock issued in exchange for accounts payable, amount 120 $ 0 0 0 0 120 0
Balance, amount at Apr. 30, 2024 $ 17,964 $ 2 $ 0 $ 0 $ 0 $ 87,732 $ (69,770)
Balance, shares at Apr. 30, 2024   17,411   1,503